[1]
Opalska, L. et al. 2024. Insights into the Efficacy of GLP-1 Agonists and Dual Agonists: Semaglutide and Tirzepatide in Obesity and Type 2 Diabetes. Quality in Sport. 35, (Dec. 2024), 56425. DOI:https://doi.org/10.12775/QS.2024.35.56425.